Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
deals
5
×
investing
5
×
life sciences
national blog main
boston blog main
boston
boston top stories
fda
national top stories
san francisco blog main
roche
san francisco top stories
sanofi
startups
achaogen
adams street partners
akouos
allosteric
amgen
antibiotics
astellas pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
avapritinib
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
blueprint medicines
brace pharma
california institute for biomedical research
cancer
cancer drugs
cleva pharma
cobimetinib
cstone pharmaceuticals
decibel therapeutics
drug discovery
drug resistance
What
medicines
5
×
drug
therapeutics
cancer
disease
fda
ipo
targets
address
adds
affects
ago
allosteric
americans
approval
approved
bacteria
biopharma
blueprint
business
candidate
clinic
company
currently
date
despite
developing
elusive
exited
family
fighting
frequency
hardest
hearing
hit
hotspot
hottest
hunters
infections
infectious
Language
unset
Current search:
deals
×
medicines
×
investing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
